Earnings Feed
Start Free
Home/Filings/4/0001179110-21-006020
4//SEC Filing

Weber David M 4

Accession 0001179110-21-006020

CIK 0000815094other
View on SEC.govCompany Profile

Filed

May 26, 8:00 PM ET

Accepted

May 27, 4:55 PM ET

Size

20.1 KB

Accession

0001179110-21-006020

Insider Transaction Report

Form 4
Period: 2021-05-25
ABIOMED INCABMD
Weber David M
Chief Operating Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-05-25+4,969→ 4,969 total
    Exercise: $283.88From: 2022-05-25Exp: 2031-05-25→ Common Stock (4,969 underlying)
  • Award

    Common Stock, $.01 par value

    2021-05-25+2,687→ 126,337 total
Holdings

  • Common Stock, $.01 par value

    (indirect: By Trust)
    15,497

  • Stock Option (right to buy)

    Exercise: $66.25From: 2016-05-13Exp: 2025-05-13→ Common Stock (0 underlying)
    10,000

  • Stock Option (right to buy)

    Exercise: $99.62From: 2017-05-24Exp: 2026-05-24→ Common Stock (0 underlying)
    7,000

  • Stock Option (right to buy)

    Exercise: $134.51From: 2018-05-15Exp: 2027-05-15→ Common Stock (0 underlying)
    8,000

  • Stock Option (Right to Buy)

    Exercise: $21.55From: 2015-05-14Exp: 2024-05-14→ Common Stock (0 underlying)
    10,825

  • Stock Option (Right to Buy)

    Exercise: $266.39From: 2020-05-30Exp: 2029-05-30→ Common Stock (0 underlying)
    6,000

  • Stock Option (Right to Buy)

    Exercise: $223.90From: 2021-05-29Exp: 2030-05-29→ Common Stock (0 underlying)
    5,000

  • Stock Option (right to buy)

    Exercise: $381.97From: 2019-05-16Exp: 2028-05-16→ Common Stock (0 underlying)
    6,500
Footnotes (4)
  • [F1]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
  • [F2]These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
  • [F3]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
  • [F4]Consists of restricted stock units granted to the reporting person. One third of the restricted stock units will vest and the underlying shares will be issued to the reporting person on each of May 25, 2022, May 25, 2023 and May 25, 2024, so long as the reporting person continues to be employed by the issuer on the vesting dates.

Documents

2 files

Issuer

ABIOMED INC

CIK 0000815094

→
Entity typeother

Related Parties

1
  • filerCIK 0001399519

Filing Metadata

Form type
4
Filed
May 26, 8:00 PM ET
Accepted
May 27, 4:55 PM ET
Size
20.1 KB
View on SEC.gov